Impaired DNASE1L3 Activity from a Novel Mutation Identified in Monogenic Systemic Lupus Erythematosus

Journal of Rheumatology · Published 2026-08-01 · DOI 10.3899/jrheum.2026-0447.71

Authors (8)

Piya Lahiry, Barbara Osypa, Albena Pramatarova, Mathieu Mancini, Benoit Brilland, Ines Colmegna, Rosie Scuccimarri, David Langlais

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Lahiry, P., Osypa, B., Pramatarova, A., et al. (2026). Impaired DNASE1L3 Activity from a Novel Mutation Identified in Monogenic Systemic Lupus Erythematosus. Journal of Rheumatology. https://doi.org/10.3899/jrheum.2026-0447.71

Related articles

• Effectiveness of Upadacitinib in Patients with Rheumatoid Arthritis in Canadian Real-World Practice: Final Results from the Close-Up Post-Marketing Observational Study · Journal of Rheumatology · 2026 · Same journal
• Multisystem Sarcoidosis with Extensive Neurologic, Musculoskeletal, Pulmonary, Lymphatic, and Cutaneous Involvement: A Case Report · Journal of Rheumatology · 2026 · Same journal
• Physical Rehabilitation Interventions for Hand Function in People with Systemic Sclerosis. A Scoping Review · Journal of Rheumatology · 2026 · Same journal
• Characteristics of a Pilot Rheumatology Rapid Access Clinic in Toronto, Canada · Journal of Rheumatology · 2026 · Same journal
• Longitudinal ANA and ENA Dynamics in Preclinical Systemic Autoimmune Rheumatic Diseases: A Retrospective Cohort Study · Journal of Rheumatology · 2026 · Same journal
• VEXAS Syndrome: A Clinical Case Series from Calgary · Journal of Rheumatology · 2026 · Same journal
• Combination Advanced Therapy Exposures in Immune-Mediated Inflammatory Diseases Are Associated with Increased Infection Risk, Even with Short Median Duration · Journal of Rheumatology · 2026 · Same journal
• Persistence and Effectiveness Across PsA Patient Subgroups with Guselkumab and IL-17 Inhibitors: 6-Month Results of the Psabiond Observational Study · Journal of Rheumatology · 2026 · Same journal
• How Often does Follow up 18F-FDG PET/ct Improve or Become Inactive in Patients with Active Large Vessel-Giant Cell Arteritis (LV-GCA) After Escalating Treatment: A Systematic Review · Journal of Rheumatology · 2026 · Same journal
• Feasibility Study to Implement Quality Indicator Toolkits for Rehabilitation After Total Hip and Knee Replacement: Patient and Clinician Toolkit User Metrics · Journal of Rheumatology · 2026 · Same journal